Integrated Quantitative Investments LLC Makes New $1.03 Million Investment in Avanos Medical, Inc. (NYSE:AVNS)

Integrated Quantitative Investments LLC purchased a new stake in Avanos Medical, Inc. (NYSE:AVNS - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 64,780 shares of the company's stock, valued at approximately $1,031,000. Integrated Quantitative Investments LLC owned 0.14% of Avanos Medical as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in the business. Quarry LP bought a new stake in Avanos Medical in the 3rd quarter valued at about $42,000. Quantbot Technologies LP acquired a new position in shares of Avanos Medical during the fourth quarter worth approximately $64,000. Intech Investment Management LLC bought a new position in shares of Avanos Medical in the 3rd quarter worth $207,000. Atom Investors LP acquired a new stake in Avanos Medical in the 3rd quarter valued at $210,000. Finally, EP Wealth Advisors LLC bought a new stake in Avanos Medical during the 3rd quarter valued at $212,000. 95.17% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Avanos Medical

In other news, SVP Kerr Holbrook sold 7,000 shares of the firm's stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $15.25, for a total transaction of $106,750.00. Following the completion of the sale, the senior vice president now directly owns 82,047 shares of the company's stock, valued at $1,251,216.75. This trade represents a 7.86 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 2.64% of the company's stock.

Avanos Medical Stock Up 0.2 %

Shares of AVNS stock traded up $0.02 during trading hours on Wednesday, reaching $12.41. The company had a trading volume of 157,685 shares, compared to its average volume of 320,022. The company has a market cap of $571.04 million, a price-to-earnings ratio of 36.49 and a beta of 1.15. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46. Avanos Medical, Inc. has a 12 month low of $12.18 and a 12 month high of $25.36. The business has a fifty day simple moving average of $15.21 and a 200-day simple moving average of $17.76.

Avanos Medical (NYSE:AVNS - Get Free Report) last issued its quarterly earnings data on Wednesday, February 26th. The company reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.03. The business had revenue of $179.60 million for the quarter, compared to analysts' expectations of $177.23 million. Avanos Medical had a return on equity of 4.70% and a net margin of 2.30%. On average, research analysts expect that Avanos Medical, Inc. will post 1.32 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, StockNews.com upgraded shares of Avanos Medical from a "hold" rating to a "buy" rating in a report on Wednesday, March 19th.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.